SPY понизился на премаркете

Ближайший уровень поддержки по SPY – 200.25 уровень сопротивления – 200.90



CMGE продажа от 28.50

MSI продажа от 61

Gapping up/down: BURL +6% and CASY +4% after earnings/guidance, BNNY and IPAS +37% on M&A news, BNNY peers trading higher, MZOR +7% on CFDA approval, THLD +15% on initiation; FRAN -12%, TITN -11%, and FCEL -10% after earnings, POT -1% after dg

Gapping up
In reaction to strong earnings/guidance: BURL +6.1%, CASY +4.1%, TPLM +3.4%, KFY +3%, HELI +2.2%, HDS +1.9%, CTLT +1.1%.

M&A news:BNNY +37.4% (to be acquired by General Mills (GIS) for $46 per share in cash), IPAS +36.8% (to explore strategic alternatives), GFIG +7.2% (BGC Partners (BGCP) announces intent to commence all cash tender offer to acquire GFI Group Shares for $5.25 Per Share).

Select BNNY peers showing strength: WWAV +5.5%, BDBD +4.5%, HAIN +3.8%.

Select Mad Money mentions trading higher: ATK +2%, NFLX +1.6%, LMT +1.1%, RTN +0.9%, SKX +0.5%.

Other news: MZOR +6.8% (receives China CFDA approval for its Renaissance Systems), IDTI +4.8% (working closely with Intel (INTC) on the development of wireless charging solutions), NVFY +3.8% (announces purchase order fulfilled with IKEA China), STKL +3.6% (will further expand its Modesto, California aseptic processing and packaging operation), GTAT +3.1% (ahead of Apple's product event — speculation as supplier), HSOL +2.6% (signs its second supply agreement with Baotou Shansheng New Energy for delivery of 50 MW of HSOL's PV modules), PRTS +2.2% (named Michael Yoshida Interim Chief Financial Officer; co has initiated a search for a new CFO), ABB +2.1% (announces $4 bln share repurchase), SGMS +1.9% (awarded three-year instant game contract extension with Colorado lottery), ADXS +1.5% (announces completion of an End-of-Phase 2 Meeting with the FDA for its lead Lm-LLO cancer immunotherapy), GLYC +1.1% (announced that data from preclinical studies demonstrating the in vivo efficacy of GMI-1051 will be presented), IMMR +1% (following late move higher on increased volume), MITK +1% (announced that it has agreed to end all pending litigation with Top Image Systems (TISA) andTIS America), JCP +1% (subsidiary commences underwritten public offering of $350 mln aggregate principal amount of senior unsecured notes), LPCN +0.9% (announces first patient dosed in Phase 1 study in pregnant women of LPCN 1107, potentially the first oral product for the prevention of preterm birth), AAPL +0.7% (trading higher in advance of product event).


Analyst comments: THLD +15% (initiated with a Buy at Cantor Fitzgerald), CTIC +9.7% (initiated with a Overweight at Piper Jaffray), ECYT +5.5% (initiated with a Buy at Cantor Fitzgerald), CEMP +4.2% (receives $10 mln milestone payment from Toyama Chemical Co), MACK +3.5% (initiated with a Buy at Cantor Fitzgerald ), MBLY +3.4% (hearing positive Morgan Stanley comments as catalyst), SYF +3.2% (initiated with a Overweight at JP Morgan and Morgan Stanley, among others), GCA +2.8% (upgraded to Buy at Stifel following MGAM purchase), LYG +2.3% (upgraded to Overweight from Neutral at HSBC Securities), MT +1.9% (upgraded to Outperform from Neutral at Credit Suisse), VRTU +1.7% (upgraded to Overweight from Neutral at JP Morgan), BCS +1.6% (upgraded to Overweight from Neutral at HSBC Securities), MDVN +1.4% (upgraded to Outperform from Mkt Perform at Bernstein), AMRI +1.3% (initiated with a Overweight at JP Morgan), DHI +1.2% (upgraded to Overweight from Neutral at JP Morgan)

Gapping down
In reaction to disappointing earnings/guidance: FRAN -11.7%, TITN -10.7%, FCEL -10.5%, PBY -7.1%, CNSI -5%, FUEL -2.4%, (announces CFO transition and reaffirms prior guidance for the 3Q14 and FY14 ), PTN -1%.

Other news: RADA -5.5% (following 130%+ surge higher following intraday earnings release), AVP -4.1% (announced resignation of CFO Kimberly Ross; Robert Loughran appointed acting CFO effective October 2, 2014), PF -3.7% (announced secondary offering of 15 mln shares of common stock by selling shareholders), DOC -2.6% (announced public offering of 9 mln shares of common stock; announces over $300 mln of commitments for new unsecured revolving credit facility), BKD -1.7% (prices public offering of 8,955,223 shares of Common Stock at $33.50/share), TNET -1.3% (announced commencement of secondary public offering of 10,500,000 shares by stockholders), AKS -1.3% (still checking), WBAI -0.9% (late weakness on cautious Muddy Waters mention).

Analyst comments: LUV -1.1% (initiated with a Neutral at Credit Suisse), POT -1% (downgraded to Underperform from Mkt Perform at Cowen), MOS -0.8% (downgraded to Sector Perform from Outperform at RBC Capital Mkts), JBLU -0.7% (initiated with a Underperform at Credit Suisse), CVX -0.7% (downgraded to Underperform from Neutral at BofA/Merrill).

Оригинал статьи: gtstocks.com/analytics-09-09-2014.html